• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

探索营养对非酒精性脂肪肝病管理的影响:揭示各种食物、食物成分和化合物的作用。

Exploring the Impact of Nutrition on Non-Alcoholic Fatty Liver Disease Management: Unveiling the Roles of Various Foods, Food Components, and Compounds.

机构信息

Department of Clinical Pharmacology, Medical University of Lodz, 90-153 Lodz, Poland.

Students' Research Club, Department of Clinical Pharmacology, Medical University of Lodz, 90-153 Lodz, Poland.

出版信息

Nutrients. 2023 Jun 22;15(13):2838. doi: 10.3390/nu15132838.

DOI:10.3390/nu15132838
PMID:37447164
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10343927/
Abstract

There is a need to introduce standardized treatment options for non-alcoholic fatty liver disease (NAFLD) due to its global prevalence and the complications of this disease. Many studies have revealed that food-derived substances may be beneficial in dealing with this disease. Therefore, this review aims to evaluate the recently published studies on the food-derived treatment options for NAFLD. A comprehensive search of the PubMed database using keywords such as "NAFLD", "nutrition", "food", "derived", "therapy", and "guidelines" yielded 219 relevant papers for our analysis, published from 2004 to 2023. The results show the significant benefits of food-derived treatment in NAFLD therapy, including improvements in liver histology, hepatic fat amounts, anthropometric measures, lipid profile, and other metabolic measures. The availability of the substances discussed makes them a significant adjuvant in the treatment of this disease. The usefulness of Viusid as additional therapy to diet and physical activity should be emphasized due to improvements in liver histology; however, many other substances lead to a decrease in liver fat amounts including, e.g., berberine or omega-3 fatty acids. In addition, the synbiotic Protexin seems to be useful in terms of NAFLD treatment, especially because it is effective in both obese and lean subjects. Based on the latest research results, we suggest revising the therapeutic recommendations for patients suffering from NAFLD.

摘要

由于非酒精性脂肪性肝病 (NAFLD) 的全球患病率及其并发症,有必要引入标准化的治疗方案。许多研究表明,食物衍生物质可能对治疗这种疾病有益。因此,本综述旨在评估最近发表的关于 NAFLD 食物衍生治疗方法的研究。通过使用“NAFLD”、“营养”、“食物”、“衍生”、“治疗”和“指南”等关键词,对 PubMed 数据库进行全面搜索,共获得 219 篇相关论文,发表时间为 2004 年至 2023 年。结果表明,食物衍生治疗在 NAFLD 治疗中具有显著益处,包括改善肝脏组织学、肝内脂肪量、人体测量指标、血脂谱和其他代谢指标。所讨论物质的可用性使它们成为治疗这种疾病的重要辅助手段。由于改善了肝脏组织学,应该强调将 Viusid 作为饮食和体育锻炼的附加疗法的用处;然而,许多其他物质,如小檗碱或ω-3 脂肪酸,可导致肝脂肪量减少。此外,益生菌 Protexin 似乎在 NAFLD 治疗方面也很有用,特别是因为它对肥胖和瘦人群体都有效。基于最新的研究结果,我们建议修订患有 NAFLD 患者的治疗建议。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69be/10343927/ce1e2e7f635c/nutrients-15-02838-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69be/10343927/c45e9f3cf4b6/nutrients-15-02838-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69be/10343927/ce1e2e7f635c/nutrients-15-02838-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69be/10343927/c45e9f3cf4b6/nutrients-15-02838-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69be/10343927/ce1e2e7f635c/nutrients-15-02838-g002.jpg

相似文献

1
Exploring the Impact of Nutrition on Non-Alcoholic Fatty Liver Disease Management: Unveiling the Roles of Various Foods, Food Components, and Compounds.探索营养对非酒精性脂肪肝病管理的影响:揭示各种食物、食物成分和化合物的作用。
Nutrients. 2023 Jun 22;15(13):2838. doi: 10.3390/nu15132838.
2
Amelioration of non-alcoholic fatty liver disease by targeting adhesion G protein-coupled receptor F1 ().靶向黏附 G 蛋白偶联受体 F1 () 改善非酒精性脂肪性肝病。
Elife. 2023 Aug 15;12:e85131. doi: 10.7554/eLife.85131.
3
Lean non-alcoholic fatty liver disease patients had comparable total caloric, carbohydrate, protein, fat, iron, sleep duration and overtime work as obese non-alcoholic fatty liver disease patients.瘦非酒精性脂肪性肝病患者的总热量、碳水化合物、蛋白质、脂肪、铁、睡眠时间和加班时间与肥胖非酒精性脂肪性肝病患者相当。
J Gastroenterol Hepatol. 2019 Jan;34(1):256-262. doi: 10.1111/jgh.14360. Epub 2018 Jul 16.
4
Nutrition and physical activity in NAFLD: an overview of the epidemiological evidence.非酒精性脂肪性肝病(NAFLD)中的营养与身体活动:流行病学证据概述。
World J Gastroenterol. 2011 Aug 7;17(29):3377-89. doi: 10.3748/wjg.v17.i29.3377.
5
From sugar to liver fat and public health: systems biology driven studies in understanding non-alcoholic fatty liver disease pathogenesis.从糖到肝脂肪和公共健康:系统生物学驱动的非酒精性脂肪性肝病发病机制研究。
Proc Nutr Soc. 2019 Aug;78(3):290-304. doi: 10.1017/S0029665119000570. Epub 2019 Mar 29.
6
The role of nutrition in non-alcoholic fatty liver disease: Pathophysiology and management.营养在非酒精性脂肪性肝病中的作用:病理生理学与管理
Liver Int. 2020 Feb;40 Suppl 1:102-108. doi: 10.1111/liv.14360.
7
What's New in the Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD).非酒精性脂肪性肝病(NAFLD)治疗的新进展
J Clin Med. 2023 Feb 26;12(5):1852. doi: 10.3390/jcm12051852.
8
Omega-3 fatty acids for the treatment of non-alcoholic fatty liver disease.ω-3 脂肪酸治疗非酒精性脂肪性肝病。
World J Gastroenterol. 2012 Nov 7;18(41):5839-47. doi: 10.3748/wjg.v18.i41.5839.
9
Efficacy of the Omega-3 Index in predicting non-alcoholic fatty liver disease in overweight and obese adults: a pilot study.ω-3指数预测超重和肥胖成年人非酒精性脂肪性肝病的疗效:一项初步研究。
Br J Nutr. 2015 Sep 14;114(5):780-7. doi: 10.1017/S0007114515002305. Epub 2015 Jul 23.
10
Omega-3 Fatty Acids and Fatty Liver Disease in Children.儿童中的欧米伽-3脂肪酸与脂肪肝疾病
Adv Food Nutr Res. 2018;85:59-77. doi: 10.1016/bs.afnr.2018.03.001. Epub 2018 Apr 12.

引用本文的文献

1
Fast food consumption and risk of non-alcoholic fatty liver disease: a systematic review and meta-analysis.快餐消费与非酒精性脂肪性肝病风险:一项系统评价和荟萃分析。
Front Public Health. 2025 Jul 30;13:1600826. doi: 10.3389/fpubh.2025.1600826. eCollection 2025.
2
Nutritional Management for Chronic Liver Disease-Current Trends and Future Prospects.慢性肝病的营养管理——当前趋势与未来展望
Nutrients. 2025 Feb 5;17(3):579. doi: 10.3390/nu17030579.
3
Evaluating Bioactive-Substance-Based Interventions for Adults with MASLD: Results from a Systematic Scoping Review.

本文引用的文献

1
Pomegranate variety and pomegranate plant part, relevance from bioactive point of view: a review.从生物活性角度看石榴品种及石榴植株部位的相关性:综述
Bioresour Bioprocess. 2021 Jan 3;8(1):2. doi: 10.1186/s40643-020-00351-5.
2
Type 2 Diabetes Mellitus, Non-Alcoholic Fatty Liver Disease, and Metabolic Repercussions: The Vicious Cycle and Its Interplay with Inflammation.2 型糖尿病、非酒精性脂肪性肝病和代谢反应:恶性循环及其与炎症的相互作用。
Int J Mol Sci. 2023 Jun 2;24(11):9677. doi: 10.3390/ijms24119677.
3
What's New in the Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD).
评估基于生物活性物质的干预措施对患有代谢功能障碍相关脂肪性肝病(MASLD)的成年人的影响:一项系统综述的结果
Nutrients. 2025 Jan 26;17(3):453. doi: 10.3390/nu17030453.
4
Diet quality and physical activity affect metabolic dysfunction-associated steatotic liver disease, metabolic dysfunction and etiology-associated steatohepatitis, and compensated advanced chronic liver disease among United States adults: NHANES 2017-2020.饮食质量和身体活动对美国成年人中与代谢功能障碍相关的脂肪性肝病、代谢功能障碍和病因相关的脂肪性肝炎以及代偿期晚期慢性肝病有影响:2017 - 2020年美国国家健康与营养检查调查(NHANES)
Front Nutr. 2025 Jan 8;11:1505970. doi: 10.3389/fnut.2024.1505970. eCollection 2024.
5
Trends in Oxidative Balance Score and Prevalence of Metabolic Dysfunction-Associated Steatotic Liver Disease in the United States: National Health and Nutrition Examination Survey 2001 to 2018.美国氧化平衡评分趋势和代谢功能障碍相关脂肪性肝病患病率:2001 年至 2018 年全国健康和营养调查。
Nutrients. 2023 Nov 27;15(23):4931. doi: 10.3390/nu15234931.
6
Controlled attenuation parameters to assess liver steatosis in obese patients with polycystic ovary syndrome.控制衰减参数评估肥胖多囊卵巢综合征患者的肝脂肪变性。
Front Endocrinol (Lausanne). 2023 Aug 31;14:1241734. doi: 10.3389/fendo.2023.1241734. eCollection 2023.
非酒精性脂肪性肝病(NAFLD)治疗的新进展
J Clin Med. 2023 Feb 26;12(5):1852. doi: 10.3390/jcm12051852.
4
Health Benefits of Coffee Consumption for Cancer and Other Diseases and Mechanisms of Action.咖啡消费对癌症和其他疾病的健康益处及其作用机制。
Int J Mol Sci. 2023 Jan 31;24(3):2706. doi: 10.3390/ijms24032706.
5
Citrus Bergamia and Cynara Cardunculus Reduce Serum Uric Acid in Individuals with Non-Alcoholic Fatty Liver Disease.佛手柑和蓟降低非酒精性脂肪肝患者的血清尿酸。
Medicina (Kaunas). 2022 Nov 26;58(12):1728. doi: 10.3390/medicina58121728.
6
Update on Omega-3 Polyunsaturated Fatty Acids on Cardiovascular Health.关于 ω-3 多不饱和脂肪酸对心血管健康影响的最新研究进展。
Nutrients. 2022 Dec 3;14(23):5146. doi: 10.3390/nu14235146.
7
Irisin Is Related to Non-Alcoholic Fatty Liver Disease (NAFLD).鸢尾素与非酒精性脂肪性肝病(NAFLD)相关。
Biomedicines. 2022 Sep 11;10(9):2253. doi: 10.3390/biomedicines10092253.
8
Danshao Shugan Granule therapy for non-alcoholic fatty liver disease.大枣疏肝颗粒治疗非酒精性脂肪性肝病。
Lipids Health Dis. 2022 Aug 23;21(1):76. doi: 10.1186/s12944-022-01689-9.
9
A new nutraceutical (Livogen Plus®) improves liver steatosis in adults with non-alcoholic fatty liver disease.一种新的营养保健品(Livogen Plus®)可改善非酒精性脂肪性肝病成年患者的肝脏脂肪变性。
J Transl Med. 2022 Aug 19;20(1):377. doi: 10.1186/s12967-022-03579-1.
10
The effects of vitamin B12 supplementation on metabolic profile of patients with non-alcoholic fatty liver disease: a randomized controlled trial.维生素 B12 补充对非酒精性脂肪性肝病患者代谢特征的影响:一项随机对照试验。
Sci Rep. 2022 Aug 18;12(1):14047. doi: 10.1038/s41598-022-18195-8.